Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Mar 31, 2025 | (FY)Mar 31, 2024 | (FY)Mar 31, 2023 | (FY)Mar 31, 2022 | (FY)Mar 31, 2021 | (FY)Mar 31, 2020 | (FY)Mar 31, 2019 | (FY)Mar 31, 2018 | (FY)Mar 31, 2017 | (FY)Mar 31, 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow (Indirect Method) | ||||||||||
| Cash from operating activities | -43.58%11.08B | 285.47%19.63B | 580.83%5.09B | 52.32%-1.06B | -9,995.45%-2.22B | -100.63%-22M | -74.49%3.47B | -7.80%13.59B | -11.22%14.74B | 496.12%16.61B |
| Net profit before non-cash adjustment | 102.71%15.5B | -2.24%7.65B | 1,113.34%7.82B | 94.11%-772M | -902.33%-13.11B | -76.78%1.63B | -54.96%7.04B | 25.91%15.62B | 81.88%12.41B | 69.68%6.82B |
| Total adjustment of non-cash items | -118.74%-1.84B | 1,003.31%9.81B | -213.84%-1.09B | -89.54%954M | 4,753.19%9.12B | -95.18%188M | 220.79%3.9B | 5,695.24%1.22B | -99.54%21M | -0.37%4.52B |
| -Depreciation and amortization | -1.10%5.69B | 0.28%5.75B | 1.61%5.73B | -16.03%5.64B | -0.83%6.72B | 13.91%6.77B | 4.41%5.95B | 8.50%5.7B | 0.81%5.25B | 18.42%5.21B |
| -Reversal of impairment losses recognized in profit and loss | 20.82%383M | --317M | --0 | -78.34%684M | --3.16B | ---- | -1.89%259M | --264M | ---- | 29.27%817M |
| -Share of associates | 63.67%-392M | -15.15%-1.08B | 30.02%-937M | -31.53%-1.34B | 12.39%-1.02B | 33.30%-1.16B | 19.28%-1.74B | 25.94%-2.16B | -1.82%-2.91B | -4.68%-2.86B |
| -Disposal profit | -52,800.00%-5.29B | 99.83%-10M | -45.83%-5.97B | -2,656.88%-4.09B | 128.88%160M | -105.95%-554M | -11.16%-269M | -240.85%-242M | -187.65%-71M | 134.91%81M |
| -Other non-cash items | -146.01%-2.22B | 5,587.06%4.83B | 44.07%85M | -44.34%59M | 102.18%106M | -1,573.54%-4.87B | 87.58%-291M | -4.41%-2.34B | -276.28%-2.24B | -48.46%1.27B |
| Changes in working capital | -219.28%-2.59B | 231.95%2.17B | -32.39%-1.64B | -170.47%-1.24B | 195.40%1.76B | 75.30%-1.85B | -130.25%-7.47B | -240.16%-3.25B | -56.01%2.32B | 191.28%5.27B |
| -Change in receivables | 114.20%4.33B | 142.61%2.02B | -292.65%-4.74B | 19.86%2.46B | -73.19%2.05B | 522.50%7.66B | -129.33%-1.81B | 201.31%6.18B | -202.33%-6.1B | -185.43%-2.02B |
| -Change in inventory | 812.06%1.42B | -1,430.77%-199M | 99.56%-13M | -380.84%-2.95B | -52.10%1.05B | 259.50%2.19B | 14.35%-1.37B | -353.64%-1.6B | -34.51%632M | 136.97%965M |
| -Change in payables | -777.96%-8.17B | -129.19%-930M | 1,007.69%3.19B | 81.12%-351M | 84.42%-1.86B | -178.70%-11.93B | 45.16%-4.28B | -202.13%-7.81B | 21.07%7.64B | 356.21%6.31B |
| -Provision for loans, leases and other losses | -113.09%-167M | 1,847.95%1.28B | 82.02%-73M | -178.53%-406M | 120.00%517M | 3,457.14%235M | 61.11%-7M | -112.68%-18M | 2,740.00%142M | -61.54%5M |
| Dividends paid (cash flow from operating activities) | ||||||||||
| Dividends received (cash flow from operating activities) | ||||||||||
| Interest paid (cash flow from operating activities) | 58.81%-421M | -101.58%-1.02B | -89.18%-507M | -27.62%-268M | 35.98%-210M | -893.94%-328M | -175.00%-33M | 80.95%-12M | 52.63%-63M | -46.15%-133M |
| Interest received (cash flow from operating activities) | 85.32%2.83B | 16.05%1.53B | -42.50%1.32B | 38.69%2.29B | -38.72%1.65B | -0.22%2.69B | -5.04%2.7B | 49.08%2.84B | -13.84%1.91B | -17.53%2.21B |
| Tax refund paid | -120.65%-3.72B | 21.99%-1.69B | -64.38%-2.16B | -12.98%-1.31B | 45.70%-1.16B | 57.66%-2.14B | -45.12%-5.06B | -9.14%-3.49B | 25.30%-3.19B | -29.38%-4.28B |
| Other operating cash inflow (outflow) | 0 | 0 | 0 | 0 | 0 | -1M | 0 | -100.00%-2M | -1M | 0 |
| Operating cash flow | -47.07%9.76B | 393.24%18.45B | 1,156.50%3.74B | 81.80%-354M | -1,082.32%-1.95B | -81.55%198M | -91.70%1.07B | -3.41%12.93B | -7.07%13.39B | 596.14%14.41B |
| Investing cash flow | ||||||||||
| Capital expenditures | -22.29%-4.46B | ---3.65B | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Net PPE purchase and sale | 2,215.82%4.1B | -94.90%177M | 674.11%3.47B | 109.21%448M | 26.44%-4.86B | -78.22%-6.61B | 18.03%-3.71B | -14.18%-4.53B | -3.26%-3.96B | 28.03%-3.84B |
| Net business purchase and sale | 5,490.91%3.56B | -151.16%-66M | --129M | --0 | ---- | -6,360.00%-969M | -100.26%-15M | 484.73%5.79B | -664.47%-1.51B | -107.93%-197M |
| Net investment product transactions | -51.00%979M | -39.09%2B | 248.57%3.28B | 275.56%941M | -149.22%-536M | 258.06%1.09B | 75.40%-689M | -1,382.01%-2.8B | 76.78%-189M | -2,100.00%-814M |
| Net changes in other investments | 60.73%-214M | -158.29%-545M | -134.20%-211M | 166.63%617M | 24.96%-926M | -14.05%-1.23B | -89.16%-1.08B | 30.50%-572M | -68.99%-823M | -224.67%-487M |
| Investing cash flow | 290.21%3.96B | -131.25%-2.08B | 232.30%6.67B | 131.71%2.01B | 18.12%-6.33B | -40.57%-7.73B | -161.09%-5.5B | 67.53%-2.11B | -21.45%-6.48B | -75.73%-5.34B |
| Financing cash flow | ||||||||||
| Net issuance payments of debt | 100.14%12M | -69.29%-8.84B | -318.19%-5.22B | -67.40%2.39B | 87.50%7.34B | 3,133.33%3.91B | 73.13%-129M | -77.78%-480M | 44.56%-270M | -267.35%-487M |
| Net common stock issuance | --0 | 58.33%57M | 3,500.00%36M | -97.87%1M | 122.71%47M | 87.07%-207M | ---1.6B | --0 | --0 | --0 |
| Cash dividends paid | -18.86%-3.42B | -21.21%-2.87B | -80.03%-2.37B | -194.63%-1.32B | 50.33%-447M | -10.16%-900M | -14.91%-817M | -18.70%-711M | -5.64%-599M | 8.40%-567M |
| Cash dividends for minorities | -84.20%-1.13B | 48.36%-614M | -38.26%-1.19B | 11.79%-860M | 50.08%-975M | -14.55%-1.95B | -12.17%-1.71B | -7.12%-1.52B | -23.28%-1.42B | -12.51%-1.15B |
| Net other fund-raising expenses | -331.07%-4.76B | 12.52%-1.1B | -22.76%-1.26B | -23.26%-1.03B | -13.32%-834M | -908.22%-736M | 89.26%-73M | -82.31%-680M | 16.55%-373M | 67.37%-447M |
| Financing cash flow | 30.49%-9.29B | -33.63%-13.37B | -1,132.14%-10.01B | -115.83%-812M | 4,282.91%5.13B | 102.71%117M | -27.54%-4.33B | -27.43%-3.39B | -0.34%-2.66B | 36.22%-2.65B |
| Net cash flow | ||||||||||
| Beginning cash position | 19.06%39.13B | 11.93%32.86B | 7.96%29.36B | -9.13%27.2B | -20.67%29.93B | -18.49%37.73B | 16.62%46.28B | 5.56%39.69B | 18.67%37.6B | -2.68%31.68B |
| Current changes in cash | 48.03%4.43B | 646.63%2.99B | -52.26%401M | 126.73%840M | 57.59%-3.14B | 15.28%-7.41B | -217.61%-8.75B | 75.09%7.44B | -33.84%4.25B | 225.29%6.42B |
| Effect of exchange rate changes | -98.99%33M | 5.45%3.27B | 134.39%3.1B | 222.68%1.32B | 205.94%410M | -303.68%-387M | 122.59%190M | 61.03%-841M | -328.17%-2.16B | -116.33%-504M |
| Cash adjustments other than cash changes | --1M | ---- | 0.00%1M | --1M | ---- | --1M | ---- | ---- | 0.00%-1M | -100.09%-1M |
| End cash Position | 11.41%43.59B | 19.06%39.13B | 11.93%32.86B | 7.96%29.36B | -9.13%27.2B | -20.67%29.93B | -18.49%37.73B | 16.62%46.28B | 5.56%39.69B | 18.67%37.6B |
| Free cash flow | -64.16%5.3B | 6,092.47%14.8B | 105.50%239M | 36.73%-4.35B | -6.18%-6.87B | -79.98%-6.47B | -144.07%-3.6B | -12.63%8.16B | -10.77%9.34B | 389.46%10.47B |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |